Matinas BioPharma announces board member Herbert Conrad's retirement

Matinas BioPharma Holdings, Inc. (NYSE: MTNB) announced today the resignation of board member Herbert Conrad. Effective Wednesday, Mr. Conrad stepped down from his role due to retirement. According to InvestingPro data, the company maintains a strong liquidity position with more cash than debt on its balance sheet.

The company, headquartered in Bedminster, New Jersey, confirmed that Mr. Conrad's departure from the board and his committee positions was not due to any disagreement or shift in the company's direction. His resignation from the Audit and Nominating and Corporate Governance Committees took effect on February 6, 2025.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Hinge Health signs $86M office lease in San Francisco
• Entera Bio Ltd. (ENTX) files for 134.8M share offering by selling stockholders